GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (FRA:3D7) » Definitions » Additional Paid-In Capital

Willow Biosciences (FRA:3D7) Additional Paid-In Capital : €4.43 Mil(As of Sep. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Willow Biosciences Additional Paid-In Capital?


Willow Biosciences's quarterly additional paid-in capital increased from Mar. 2024 (€5.08 Mil) to Jun. 2024 (€5.09 Mil) but then stayed the same from Jun. 2024 (€5.09 Mil) to Sep. 2024 (€4.43 Mil).

Willow Biosciences's annual additional paid-in capital increased from Dec. 2021 (€4.08 Mil) to Dec. 2022 (€5.09 Mil) but then declined from Dec. 2022 (€5.09 Mil) to Dec. 2023 (€5.00 Mil).


Willow Biosciences Additional Paid-In Capital Historical Data

The historical data trend for Willow Biosciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Additional Paid-In Capital Chart

Willow Biosciences Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.28 2.75 4.08 5.09 5.00

Willow Biosciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.04 5.00 5.08 5.09 4.43

Willow Biosciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Willow Biosciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Willow Biosciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Willow Biosciences Business Description

Traded in Other Exchanges
Address
202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6
Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.

Willow Biosciences Headlines

No Headlines